Duchenne muscular dystrophy (DMD)

CRO

EMA gives support to Duchenne trial simulation platform

The EMA sent a letter of support for a model-based clinical trial simulation platform to find new treatments for Duchenne muscular dystrophy.
Joseph Keenan Jan 26, 2023 5:00am

Fresh from Vertex payday, Entrada's DMD plans derailed by FDA

Dec 20, 2022 8:45am

Sarepta preps $.12B war chest for DMD gene therapy

Nov 3, 2022 10:02am

Santhera loses interest in pulmonary drug to focus on DMD

Oct 31, 2022 10:25am

Sarepta, freed from phase 2 clinical hold, picks up momentum

Sep 6, 2022 11:28am

Sarepta to seek an early swift review for Duchenne gene therapy

Jul 29, 2022 9:20am